Hypertension Diagnostics Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.001
- Today's High:
- $0.001
- Open Price:
- $0.001
- 52W Low:
- $0.0009
- 52W High:
- $0.0049
- Prev. Close:
- $0.001
- Volume:
- 25500
Company Statistics
- Market Cap.:
- $654859
- Book Value:
- -0.091
- Revenue TTM:
- $3.79 million
- Operating Margin TTM:
- 0.02%
- Gross Profit TTM:
- $954474
- Profit Margin:
- -3.31%
- Return on Assets TTM:
- 0.03%
- Return on Equity TTM:
- 0%
Company Profile
Hypertension Diagnostics Inc had its IPO on 1998-08-07 under the ticker symbol HDII.
The company operates in the Financial Services sector and Shell Companies industry. Hypertension Diagnostics Inc has a staff strength of 0 employees.
Stock update
Shares of Hypertension Diagnostics Inc opened at $0 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0 - $0, and closed at $0.
This is a 0% increase from the previous day's closing price.
A total volume of 25,500 shares were traded at the close of the day’s session.
In the last one week, shares of Hypertension Diagnostics Inc have slipped by -37.5%.
Hypertension Diagnostics Inc's Key Ratios
Hypertension Diagnostics Inc has a market cap of $654859, indicating a price to book ratio of 0 and a price to sales ratio of 0.1511.
In the last 12-months Hypertension Diagnostics Inc’s revenue was $3.79 million with a gross profit of $954474 and an EBITDA of $36706. The EBITDA ratio measures Hypertension Diagnostics Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Hypertension Diagnostics Inc’s operating margin was 0.02% while its return on assets stood at 0.03% with a return of equity of 0%.
In Q1, Hypertension Diagnostics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.
Hypertension Diagnostics Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Hypertension Diagnostics Inc’s profitability.
Hypertension Diagnostics Inc stock is trading at a EV to sales ratio of 1.3871 and a EV to EBITDA ratio of 72.7636. Its price to sales ratio in the trailing 12-months stood at 0.1511.
Hypertension Diagnostics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.28 million
- Total Liabilities
- $1.34 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Hypertension Diagnostics Inc ended 2024 with $1.28 million in total assets and $0 in total liabilities. Its intangible assets were valued at $1.28 million while shareholder equity stood at $-4751776.00.
Hypertension Diagnostics Inc ended 2024 with $0 in deferred long-term liabilities, $1.34 million in other current liabilities, 523887.00 in common stock, $-33744438.00 in retained earnings and $0 in goodwill. Its cash balance stood at $86392.00 and cash and short-term investments were $86392.00. The company’s total short-term debt was $0 while long-term debt stood at $4.69 million.
Hypertension Diagnostics Inc’s total current assets stands at $705704.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $388028.00 compared to accounts payable of $445644.00 and inventory worth $189434.00.
In 2024, Hypertension Diagnostics Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Hypertension Diagnostics Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0
- 52-Week High
- $0.0049
- 52-Week Low
- $0.0009
- Analyst Target Price
- $
Hypertension Diagnostics Inc stock is currently trading at $0 per share. It touched a 52-week high of $0.0049 and a 52-week low of $0.0049. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Hypertension Diagnostics Inc
Similar Industry Stocks (Shell Companies)
Most Active
Top Gainers
Top Losers
About
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient’s arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.